Remove BioTech Remove Connected Health Remove Health Policy Remove Primary Care
article thumbnail

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

When this occurred, it didn’t cause more than a ripple of interest outside biotech. To address that challenge, in 2017 PLM secured a $100 million (controlling interest) investment from iCarbonX , a Chinese company that is amassing patient data to discover cures for disease. But the U.S. citizens’ personal data.